PCK2: A Novel Prognostic Biomarker in Diffuse Large B-cell Lymphoma Li

1Department of Precision Clinical Laboratory, Zhanjiang Central Hospital, Guangdong Medical University (Central People’s Hospital of Zhanjiang), Zhanjiang, Guangdong, 524023, People’s Republic of China; 2Zhanjiang Institute of Clinical…

Continue Reading